shortage of glp 1 over Headlines say the GLP-1 shortage is over, but reality is different FDA Ends Compounding of GLP-1

Regulators have emphasized familiar compliance fundamentals in this context: clear disclosures of total cost and material terms, substantiation for typical results claims, and truthful, nonmanipulated testimonials and reviews with appropriate disclosure of material connections

1) As you may have heard, the FDA has approved the weight loss drug semaglutide (a GLP-1 agonist) for kids 12 and older with #obesity Good

Discover the science behind this weight loss medication and what to expect on your journey.

Providers on our platform can now send prescriptions for Zepbound vials and KwikPen, as well as Foundayo, to the LillyDirect pharmacy and access self-pay pricing for Hims & Hers customers.